Daniel Kotz

Summary

Publications

  1. ncbi Effectiveness of varenicline versus nicotine replacement therapy for smoking cessation with minimal professional support: evidence from an English population study
    Daniel Kotz
    Cancer Research UK Health Behaviour Research Centre, University College London, London, WC1E 6BT, UK
    Psychopharmacology (Berl) 231:37-42. 2014
  2. ncbi Light smokers are less likely to receive advice to quit from their GP than moderate-to-heavy smokers: a comparison of national survey data from the Netherlands and England
    Daniel Kotz
    Department of General Practice, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, The Netherlands
    Eur J Gen Pract 19:99-105. 2013
  3. doi Predictive validity of the Motivation To Stop Scale (MTSS): a single-item measure of motivation to stop smoking
    D Kotz
    Department of General Practice, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, The Netherlands
    Drug Alcohol Depend 128:15-9. 2013
  4. doi Very low rate and light smokers: smoking patterns and cessation-related behaviour in England, 2006-11
    Daniel Kotz
    Department of General Practice, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, The Netherlands
    Addiction 107:995-1002. 2012
  5. ncbi Possible reasons for elevated carbon monoxide levels in self-reported ex-smokers
    Daniel Kotz
    Department of General Practice, CAPHRI School for Public Health and Care, Maastricht University Medical Centre, PO Box 616, 6200 MD Maastricht, The Netherlands
    Nicotine Tob Res 14:900-1. 2012
  6. ncbi Did the introduction of varenicline in England substitute for or add to the use of other smoking cessation medications?
    Daniel Kotz
    Department of General Practice, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, The Netherlands
    Nicotine Tob Res 13:793-9. 2011
  7. pmc The efficacy and safety of a nicotine conjugate vaccine (NicVAX®) or placebo co-administered with varenicline (Champix®) for smoking cessation: study protocol of a phase IIb, double blind, randomized, placebo controlled trial
    Philippe H J Hoogsteder
    CAPHRI School for Public Health and Primary Care, Department of General Practice, Maastricht University, Maastricht, The Netherlands
    BMC Public Health 12:1052. 2012
  8. doi What mediates the effect of confrontational counselling on smoking cessation in smokers with COPD?
    Daniel Kotz
    Department of General Practice, School for Public Health and Primary Care CAPHRI, Maastricht University Medical Centre, Maastricht, The Netherlands
    Patient Educ Couns 76:16-24. 2009
  9. ncbi Factors associated with the use of aids to cessation in English smokers
    Daniel Kotz
    Department of General Practice, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, The Netherlands
    Addiction 104:1403-10. 2009
  10. ncbi Smoking cessation practices of Dutch general practitioners, cardiologists, and lung physicians
    Daniel Kotz
    Department of General Practice, Care and Public Health Research Institute, Maastricht University, P O Box 616, 6200 MD Maastricht, The Netherlands
    Respir Med 101:568-73. 2007

Detail Information

Publications23

  1. ncbi Effectiveness of varenicline versus nicotine replacement therapy for smoking cessation with minimal professional support: evidence from an English population study
    Daniel Kotz
    Cancer Research UK Health Behaviour Research Centre, University College London, London, WC1E 6BT, UK
    Psychopharmacology (Berl) 231:37-42. 2014
    ..The comparative effectiveness of varenicline when prescribed under routine circumstances and in the general population has not been tested...
  2. ncbi Light smokers are less likely to receive advice to quit from their GP than moderate-to-heavy smokers: a comparison of national survey data from the Netherlands and England
    Daniel Kotz
    Department of General Practice, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, The Netherlands
    Eur J Gen Pract 19:99-105. 2013
    ..The Netherlands and England are two countries with very different smoking cessation treatment climates and may vary in the extent to which GPs advise on smoking cessation...
  3. doi Predictive validity of the Motivation To Stop Scale (MTSS): a single-item measure of motivation to stop smoking
    D Kotz
    Department of General Practice, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, The Netherlands
    Drug Alcohol Depend 128:15-9. 2013
    ..The aim of this study was to assess the predictive validity and accuracy of the single-item Motivation To Stop Scale (MTSS)...
  4. doi Very low rate and light smokers: smoking patterns and cessation-related behaviour in England, 2006-11
    Daniel Kotz
    Department of General Practice, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, The Netherlands
    Addiction 107:995-1002. 2012
    ..This paper examined changes in prevalence over the past 5 years, cessation patterns, and smoking and demographic characteristics of very low rate, light and moderate-to-heavy (10+ CPD) smokers in England...
  5. ncbi Possible reasons for elevated carbon monoxide levels in self-reported ex-smokers
    Daniel Kotz
    Department of General Practice, CAPHRI School for Public Health and Care, Maastricht University Medical Centre, PO Box 616, 6200 MD Maastricht, The Netherlands
    Nicotine Tob Res 14:900-1. 2012
    ..This commentary summarizes possible explanations for this discrepancy and briefly discusses what to do when there is reason to believe that the CO measurement is incorrect...
  6. ncbi Did the introduction of varenicline in England substitute for or add to the use of other smoking cessation medications?
    Daniel Kotz
    Department of General Practice, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, The Netherlands
    Nicotine Tob Res 13:793-9. 2011
    ..Varenicline has recently been added to the market as a new drug for smoking cessation. The aim of the current study was to assess whether varenicline substituted for, or added to, the use of other smoking cessation medications...
  7. pmc The efficacy and safety of a nicotine conjugate vaccine (NicVAX®) or placebo co-administered with varenicline (Champix®) for smoking cessation: study protocol of a phase IIb, double blind, randomized, placebo controlled trial
    Philippe H J Hoogsteder
    CAPHRI School for Public Health and Primary Care, Department of General Practice, Maastricht University, Maastricht, The Netherlands
    BMC Public Health 12:1052. 2012
    ....
  8. doi What mediates the effect of confrontational counselling on smoking cessation in smokers with COPD?
    Daniel Kotz
    Department of General Practice, School for Public Health and Primary Care CAPHRI, Maastricht University Medical Centre, Maastricht, The Netherlands
    Patient Educ Couns 76:16-24. 2009
    ..Within the framework of a randomized, active treatment controlled trial, we used a mediation analysis to understand the mechanisms by which an intervention that uses confrontation with spirometry for smoking cessation achieves its effects...
  9. ncbi Factors associated with the use of aids to cessation in English smokers
    Daniel Kotz
    Department of General Practice, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, The Netherlands
    Addiction 104:1403-10. 2009
    ..To assess factors associated with the use of smoking cessation aids among smokers trying to quit in a country where these aids are widely available and free or cheap to access...
  10. ncbi Smoking cessation practices of Dutch general practitioners, cardiologists, and lung physicians
    Daniel Kotz
    Department of General Practice, Care and Public Health Research Institute, Maastricht University, P O Box 616, 6200 MD Maastricht, The Netherlands
    Respir Med 101:568-73. 2007
    ..To assess and compare the smoking cessation practices and smoking behavior of Dutch general practitioners (GPs), cardiologists, and lung physicians...
  11. doi Smoking cessation and development of respiratory health in smokers screened with normal spirometry
    Daniel Kotz
    Department of General Practice, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, P O Box 616, 6200 MD Maastricht, The Netherlands
    Respir Med 105:243-9. 2011
    ..The objective of this study was to observe the percentage of smokers screened with normal lung function that quit smoking...
  12. ncbi Development and validation of a model to predict the 10-year risk of general practitioner-recorded COPD
    Daniel Kotz
    1 Department of Family Medicine, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, The Netherlands 2 Allergy and Respiratory Research Group, Centre for Population Health Sciences, The University of Edinburgh, Edinburgh, UK
    NPJ Prim Care Respir Med 24:14011. 2014
    ..There is increasing interest in the earlier detection of, and intervention in, patients at highest risk of developing chronic obstructive pulmonary disease (COPD)...
  13. ncbi Efficacy of the nicotine vaccine 3'-AmNic-rEPA (NicVAX) co-administered with varenicline and counselling for smoking cessation: a randomized placebo-controlled trial
    Philippe H J Hoogsteder
    CAPHRI School for Public Health and Primary Care, Department of Family Medicine, Maastricht University, Maastricht, The Netherlands
    Addiction 109:1252-9. 2014
    ..The present study examined the efficacy of adding NicVAX versus placebo to varenicline and behavioural support as an aid in smoking cessation and relapse prevention...
  14. doi Healthcare financing systems for increasing the use of tobacco dependence treatment
    Ayalu A Reda
    Department of General Practice, School of Public Health and Primary care Caphri, Maastricht University Medical Center, Maastricht, Netherlands
    Cochrane Database Syst Rev 6:CD004305. 2012
    ..We hypothesized that provision of financial assistance for smokers trying to quit, or reimbursement of their care providers, could lead to an increased rate of successful quit attempts...
  15. ncbi Effect of smoke-free legislation on the incidence of sudden circulatory arrest in the Netherlands
    Dianne de Korte-de Boer
    Department of Epidemiology, Maastricht University, Maastricht, The Netherlands
    Heart 98:995-9. 2012
    ..Smoke-free legislation was implemented in two phases: a workplace ban in 2004 and an extension of this ban to the hospitality sector on 1 July 2008...
  16. ncbi Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study
    Jamie Brown
    Cancer Research UK Health Behaviour Research Centre, University College London, London, UK Department of Clinical, Educational and Health Psychology, University College London, London, UK
    Addiction 109:1531-40. 2014
    ....
  17. pmc Efficacy of confrontational counselling for smoking cessation in smokers with previously undiagnosed mild to moderate airflow limitation: study protocol of a randomized controlled trial
    Daniel Kotz
    Department of General Practice, School for Public Health and Primary Care CAPHRI, Maastricht University, Maastricht, The Netherlands
    BMC Public Health 7:332. 2007
    ....
  18. ncbi 'Real-world' effectiveness of smoking cessation treatments: a population study
    Daniel Kotz
    Department of Family Medicine, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, the Netherlands Cancer Research UK Health Behaviour Research Centre, University College London, London, UK
    Addiction 109:491-9. 2014
    ..This study assessed the association between abstinence and use of different smoking cessation treatments after adjusting for key potential confounding factors...
  19. doi No differential attrition was found in randomized controlled trials published in general medical journals: a meta-analysis
    Rik Crutzen
    CAPHRI School for Public Health and Primary Care, Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands
    J Clin Epidemiol 66:948-54. 2013
    ..This study identifies the degree of differential attrition in RCTs covering a broad spectrum of clinical areas and factors that are related to this...
  20. pmc How effective and cost-effective was the national mass media smoking cessation campaign 'Stoptober'?
    Jamie Brown
    Cancer Research UK Health Behaviour Research Centre, University College London, London WC1E 6BT, UK Electronic address
    Drug Alcohol Depend 135:52-8. 2014
    ....
  21. doi Reliability and validity of the clinical COPD questionniare and chronic respiratory questionnaire
    Ayalu A Reda
    Department of General Practice, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, The Netherlands
    Respir Med 104:1675-82. 2010
    ..The aim of this study was to investigate and compare these properties in the disease specific Clinical COPD Questionnaire (CCQ) and the Chronic Respiratory Questionnaire self-reported (CRQ-SR)...
  22. doi Incidence, prevalence, and trends of general practitioner-recorded diagnosis of peanut allergy in England, 2001 to 2005
    Daniel Kotz
    Department of General Practice, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Center, Maastricht, The Netherlands
    J Allergy Clin Immunol 127:623-30.e1. 2011
    ..Previous descriptions of the epidemiology of peanut allergy have mainly been derived from small cross-sectional studies...
  23. pmc IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study
    Dilyara G Yanbaeva
    Department of Respiratory Medicine, Nutrition and Toxicology Research Institute Maastricht NUTRIM, Maastricht University Medical Centre, Maastricht, The Netherlands
    BMC Med Genet 10:23. 2009
    ..The aim of this study was to examine the association between haplotypes of CRP, IL6 and FGB genes, systemic inflammation, COPD risk and COPD-related phenotypes (respiratory impairment, exercise capacity and body composition)...